NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

TSX · Health Information Services · CAD

kneat.com Inc (KSI.TO) Stock Analysis

kneat.com Inc (KSI.TO) is a Health Information Services stock listed on TSX and quoted in Canadian Dollar.

KSI.TO

CA$6.50

CA$0.00 (0.00%)

Last trade August 13, 2026

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare KSI.TO with… →

KSI.TO Key Statistics

As of Aug 13, 2026
Trading
Open
CA$6.50
Previous Close
CA$6.50
52-Week Range
3.23–6.50
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
1.33
Valuation
Market Cap
CA$627.72M
P/E Ratio
unprofitable
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
260.00
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
9.44
EPS (ttm)Profit attributable to each share over the last twelve months.
−0.08
Financials (FY)
Revenue (FY)
CA$63.26M+29.27%
Net Income (FY)
−CA$2.35M
Profit marginThe share of revenue left as profit after all costs and taxes.
−12.69%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
96.57M
1-Year Return
+12.65%
Dividend and dates
Avg Volume
345.91K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

KSI.TO Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+32.11%
2025−16.04%
2024+92.13%
2023+14.23%
2022−32.58%
2021+40.43%
2020+2.92%
2019+179.59%
2018+15.29%
2017 (partial year)+30.77%

As of August 13, 2026.

KSI.TO Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025CA$63.26M−CA$2.35M−3.7%
2024CA$48.94M−CA$7.73M−15.8%
2023CA$34.22M−CA$14.52M−42.4%
2022CA$23.75M−CA$9.15M−38.5%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025CA$63.26MCA$47.94M−CA$8.45M−CA$2.35M−3.7%
2024CA$48.94MCA$36.76M−CA$5.95M−CA$7.73M−15.8%
2023CA$34.22MCA$23.13M−CA$13.93M−CA$14.52M−42.4%
2022CA$23.75MCA$14.65M−CA$9.77M−CA$9.15M−38.5%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

KSI.TO Valuation vs Health Information Services Median

Median of 53 stocks
MetricKSI.TOHealth Information Services medianvs median
P/S ratio9.442.663.5x the median
Profit margin−12.69%0.00%12.7 pts below

Medians across 53 Health Information Services stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Analysis

Data-derived

Company Overview

The market values kneat.com Inc (KSI.TO) at CA$627.72M. The company sits in the Healthcare sector, in the Health Information Services industry. The company reports 343 employees.

The most recent close on file for KSI.TO is CA$6.50, dated August 13, 2026. The close was unchanged from the previous session. The 52-week range on file runs from CA$3.23 to CA$6.50. The latest close sits 101.24% above that 52-week low.

Financial Health

In fiscal 2025, kneat.com Inc reported revenue of CA$63.26M. Against the prior fiscal year total of CA$48.94M, that is a change of +29.27%. The same year closed with a net loss of CA$2.35M. The reported profit margin is −12.69%. That is 12.7 percentage points below the Health Information Services median of 0%. Earnings per share on a trailing basis come to −0.08.

Across the 4 fiscal years on file, revenue moves from CA$23.75M in 2022 to CA$63.26M in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

No trailing P/E applies: the last reported earnings figure is negative. On forward earnings the ratio is 260. Measured against sales, the shares trade at 9.44 times revenue. On price-to-sales that is 3.5 times the Health Information Services median of 2.66. 53 Health Information Services companies report these metrics, and the medians quoted come from that group.

Over the trailing twelve months the price has returned +12.65%. Across 5 years the annualized return works out at +12.80%. The reported beta is 1.33. Annualized volatility over the trailing 9 years is 56.6%.

Growth & Income

No dividend is on file for KSI.TO.

Across the complete calendar years on file, 2019 returned +179.59% and 2022 returned −32.58%. Of the 8 complete calendar years on file, 6 finished higher. So far in 2026 the price is +32.11%.

Peer Comparison

kneat.com Inc (KSI.TO) operates in the Health Information Services industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
kneat.com Inc KSI.TO CA$627.72M —
Veeva Systems Inc. VEEV CA$44.54B 45.0
BrightSpring Health Services, Inc. BTSG CA$12.02B 54.7
Tempus AI, Inc. TEM CA$11.66B —

The Health Information Services industry average P/E ratio is 41.1x. kneat.com Inc has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of August 13, 2026.

Related Health Information Services Stocks

VEEV

Veeva Systems Inc.

$44.54B

 BTSG

BrightSpring Health Services, Inc.

$12.02B

 TEM

Tempus AI, Inc.

$11.66B

 HQY

HealthEquity, Inc.

$7.95B

 HNGE

Hinge Health, Inc.

$7.45B

 WAY

Waystar Holding Corp.

$4.81B
View all Health Information Services stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 UNH

UnitedHealth Group Incorporated

$356.47B
View all Healthcare stocks →

About kneat.com Inc

kneat.com, inc., together with its subsidiaries, designs, develops, and supplies software for data and document management within regulated environments in America, Europe, and the Asia Pacific. The company offers the Kneat Gx platform, a configurable off-the-shelf application focused on validation lifecycle management and testing for biotechnology, pharmaceutical, and medical device manufacturing industries. It also provides professional services, including consulting, training, process mapping, project management, and other services. kneat.com, inc. was founded in 2007 and is based in Limerick, Ireland. As of August 11, 2026, kneat.com, inc. was taken private.

Visit website →